Pinnacle West Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.16M Sell
8,980
-560
-6% -$200K 2.15% 14
2025
Q4
$3.12M Sell
9,540
-110
-1% -$34.9K 2.03% 12
2025
Q3
$2.72M Buy
9,650
+45
+0.5% +$13.1K 1.76% 17
2025
Q2
$2.68M Sell
9,605
-115
-1% -$32.6K 1.85% 14
2025
Q1
$3.03M Buy
9,720
+25
+0.3% +$7.38K 2.19% 11
2024
Q4
$2.53M Hold
9,695
1.81% 14
2024
Q3
$3.12M Buy
9,695
+55
+0.6% +$18K 2.24% 10
2024
Q2
$3.01M Sell
9,640
-5
-0.1% -$1.47K 2.34% 10
2024
Q1
$2.74M Sell
9,645
-25
-0.3% -$7.32K 2.18% 10
2023
Q4
$2.79M Buy
9,670
+465
+5% +$127K 2.39% 6
2023
Q3
$2.47M Buy
9,205
+845
+10% +$211K 2.43% 5
2023
Q2
$1.86M Sell
8,360
-30
-0.4% -$6.96K 1.8% 11
2023
Q1
$2.03M Buy
+8,390
New +$2.06M 2.12% 8

Other funds holding AMGN

Pinnacle West Asset Management's AMGN Position: Q1 2026 in Review

Pinnacle West Asset Management reduced its Amgen (AMGN) stake by 5.9% in Q1 2026, selling an estimated $200K and leaving 8,980 shares worth $3.16M. The position accounts for 2.15% of the portfolio, ranked #14.

Pinnacle West Asset Management first reported a position in AMGN in Q1 2023 and has held it in 13 quarters since. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Pinnacle West Asset Management held 8,980 shares of Amgen worth $3.16M as of Q1 2026.
  • Pinnacle West Asset Management sold 560 Amgen shares in Q1 2026, an estimated $200K.
  • Amgen made up 2.15% of Pinnacle West Asset Management's portfolio in Q1 2026, its #14 holding.
  • Pinnacle West Asset Management first reported a position in Amgen in Q1 2023 and has held it in 13 quarters since.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Pinnacle West Asset Management's 13F filing for Q1 2026, filed 15 May 2026.